Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma — TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
| Count | 0.5 mg |
| 15 | 71610-734-15 |
| 30 | 71610-734-30 |
| 45 | 71610-734-45 |
| 60 | 71610-734-53 |
| 90 | 71610-734-60 |
| 120 | 71610-734-70 |
| 150 | 71610-734-75 |
| 180 | 71610-734-80 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20230913JK
PRINCIPAL DISPLAY PANEL — 0.5 mg
NDC 71610-734 — Alprazolam, USP 0.5 mg Tablets — Rx Only — C-IV
ALPRAZOLAM
alprazolam tablet |
| |
| |
| |
| |
| |
|
| |
Revised: 09/2023 Aphena Pharma Solutions — Tennessee, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/alprazolam-68/page/9/
